IMATINIB

imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 19225)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17885)

Indication: Chronic eosinophilic leukaemia or Hypereosinophilic syndrome
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17960)

Indication: Myelodysplastic or myeloproliferative disorder
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17886)

Indication: Malignant gastrointestinal stromal tumour
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 2 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17887)

Indication: Aggressive systemic mastocytosis with eosinophilia
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17884)

Indication: Dermatofibrosarcoma protuberans
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17890)

Indication: Gastrointestinal stromal tumour
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17826)

Indication: Acute lymphoblastic leukaemia
Treatment phase: Maintenance of first complete remission
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 2 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva

IMATINIB (11878E)

Supply only until 01/10/2027
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17829)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment

Restriction (Streamlined authority code: 17830)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 2 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva
imatinib 400 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Gastrointestinal stromal tumour
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $184.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva